Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the clinical effect of methylprednisolone lozenge in oral lichen planus
IRCT20220115053724N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone in oral lichen planus (OLP), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
methylprednisolone
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT20220115053724N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220115053724N1.